Christine Roth
Directeur/Membre du Conseil chez Vividion Therapeutics, Inc.
Provenance du réseau au premier degré de Christine Roth
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.
12
| Subsidiary | Miscellaneous Commercial Services | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christine Roth via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Connecticut | College/University | Undergraduate Degree Graduate Degree | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
| Moores Cancer Center | Corporate Officer/Principal | ||
| RAYZEBIO, INC. | Biotechnology | Chairman | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Corporate Officer/Principal | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
| American Association For Cancer Research Foundation | Director/Board Member | ||
Jewish Federation of Omaha, Inc.
 Jewish Federation of Omaha, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Federation of Omaha, Inc. offers social, educational and cultural programs through fundraising. It supports communal services in the Omaha area by establishing and accumulating assets for permanent funding resources. The company was founded in 1903 and is headquartered in Omaha, NE. | Miscellaneous Commercial Services | Director/Board Member | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member | |
| METACRINE, INC. | Biotechnology | Founder | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
| University of Greifswald | College/University | Undergraduate Degree | |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| Emory University | College/University | Doctorate Degree | |
| KURA ONCOLOGY, INC. | Biotechnology | Corporate Officer/Principal | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Trinity College | College/University | Undergraduate Degree | |
| University of Arizona | College/University | Undergraduate Degree | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| University of Tokyo | College/University | Doctorate Degree | |
| University of Groningen | College/University | Doctorate Degree | |
| Saints Cyril & Methodius University of Skopje | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 41 |
| Allemagne | 4 |
| Suisse | 3 |
| Royaume-Uni | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 67 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 22 |
| Founder | 14 |
| Chief Tech/Sci/R&D Officer | 11 |
Relations les plus connectées
| Insiders | |
|---|---|
| Richard Heyman | 33 |
| Benjamin Cravatt | 19 |
| Jeffrey Hatfield | 18 |
| Christine Siu | 15 |
| Patricia Allen | 14 |
| Marianne de Backer | 14 |
| Christian Rommel | 11 |
| Aleksandra Rizo | 8 |
| Stefan Oelrich | 6 |
| Xiaohu Deng | 5 |
| Todd Kinsella | 4 |
| Lisa Percival | 4 |
- Bourse
- Insiders
- Christine Roth
- Connexions Sociétés
